Advertisement

Research Article Free access | 10.1172/JCI116878

Potential role for interleukin-10 in the immunosuppression associated with kala azar.

B J Holaday, M M Pompeu, S Jeronimo, M J Texeira, A de A Sousa, A W Vasconcelos, R D Pearson, J S Abrams, and R M Locksley

Department of Medicine and Microbiology/Immunology, University of California, San Francisco School of Medicine 94143.

Find articles by Holaday, B. in: JCI | PubMed | Google Scholar

Department of Medicine and Microbiology/Immunology, University of California, San Francisco School of Medicine 94143.

Find articles by Pompeu, M. in: JCI | PubMed | Google Scholar

Department of Medicine and Microbiology/Immunology, University of California, San Francisco School of Medicine 94143.

Find articles by Jeronimo, S. in: JCI | PubMed | Google Scholar

Department of Medicine and Microbiology/Immunology, University of California, San Francisco School of Medicine 94143.

Find articles by Texeira, M. in: JCI | PubMed | Google Scholar

Department of Medicine and Microbiology/Immunology, University of California, San Francisco School of Medicine 94143.

Find articles by Sousa, A. in: JCI | PubMed | Google Scholar

Department of Medicine and Microbiology/Immunology, University of California, San Francisco School of Medicine 94143.

Find articles by Vasconcelos, A. in: JCI | PubMed | Google Scholar

Department of Medicine and Microbiology/Immunology, University of California, San Francisco School of Medicine 94143.

Find articles by Pearson, R. in: JCI | PubMed | Google Scholar

Department of Medicine and Microbiology/Immunology, University of California, San Francisco School of Medicine 94143.

Find articles by Abrams, J. in: JCI | PubMed | Google Scholar

Department of Medicine and Microbiology/Immunology, University of California, San Francisco School of Medicine 94143.

Find articles by Locksley, R. in: JCI | PubMed | Google Scholar

Published December 1, 1993 - More info

Published in Volume 92, Issue 6 on December 1, 1993
J Clin Invest. 1993;92(6):2626–2632. https://doi.org/10.1172/JCI116878.
© 1993 The American Society for Clinical Investigation
Published December 1, 1993 - Version history
View PDF
Abstract

Patients with acute kala azar are generally nonreactive in a number of immunologic assays, including T cell proliferation and generation of macrophage-activating cytokines, principally IFN-gamma, in response to leishmania antigens in vitro. To test for potential immunosuppressive factors, a series of T cell lines and clones were established from patients with acute kala azar, from patients after chemotherapy for kala azar, and from skin test-positive adults from the same endemic region. Although CD4+ T cell lines and clones could be readily established from the skin test-positive adults, lines and clones from acute or treated patients were heavily biased in expression of CD8+. The CD8+ cells from acute patients did not themselves release cytokines in response to leishmania antigens in vitro, but markedly affected the cytokine profile of peripheral blood mononuclear cells isolated 1 yr later after recovery. Addition of the CD8+ cells caused inhibition of lymphoproliferation and IFN-gamma release, with augmentation of IL-6 and IL-10 release. The inhibitory effects of the CD8+ cells could be partially abrogated by antibodies to IL-10 but not by antibodies to IL-4. Analysis of four patients with acute kala azar demonstrated release of IL-10 that could not be demonstrated in supernatants from asymptomatic skin test-positive individuals. Generation of IL-10 may contribute to the profound suppression of IFN-gamma release that occurs during kala azar due to Leishmania chagasi.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (December 1, 1993): No description
Advertisement
Advertisement